Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Qol Holdings Co's OCF Yield % or its related term are showing as below:
TSE:3034'
s OCF Yield % Range Over the Past 10 Years
Min: 18.83 Med: 0 Max: 18.83
Current: 18.83
During the past 13 years, the highest OCF Yield % of Qol Holdings Co was 18.83%. The lowest was 18.83%. And the median was %.
TSE:3034's OCF Yield % is ranked better than 87.78% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 5.23
vs TSE:3034: 18.83
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Qol Holdings Co OCF Yield % Related Terms
Qol Holdings Co OCF Yield % Historical Data
* Premium members only.
The historical data trend for Qol Holdings Co's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Qol Holdings Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qol Holdings Co OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Qol Holdings Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qol Holdings Co (TSE:3034) has a OCF Yield % of 18.83 as of Aug. 15, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Qol Holdings Co and its competitors. Over the past decade, Qol Holdings Co's OCF Yield % has ranged from 18.83 to 18.83. According to the industry distribution chart, Qol Holdings Co ranks #83 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 12.2%.
Is Qol Holdings Co's OCF Yield % too high?
Qol Holdings Co's current OCF Yield % is 18.83. Over the past 10 years, this metric has ranged from a low of 18.83 to a high of 18.83. The Healthcare Providers & Services industry median OCF Yield % is 5.23. Qol Holdings Co's value of 18.83 is 260% above this industry median. Based on the distribution chart, Qol Holdings Co ranks #83 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Qol Holdings Co has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qol Holdings Co's OCF Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Qol Holdings Co ranks #83 out of 679 companies for OCF Yield %. This places Qol Holdings Co in the top 12% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 5.23. Qol Holdings Co's value of 18.83 is 260% above this benchmark. Historically, Qol Holdings Co's own OCF Yield % has ranged from 18.83 to 18.83 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.23, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qol Holdings Co's current OCF Yield % of 18.83 is 260% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Qol Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qol Holdings Co's current OCF Yield % is 18.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qol Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Qol Holdings Co (TSE:3034) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,296.33, compared to a current price of 円2,638.00 — trading 14.9% above its estimated fair value. The current OCF Yield % is 18.83 and 260% above the Healthcare Providers & Services industry median of 5.23. Qol Holdings Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Qol Holdings Co (TSE:3034), the current OCF Yield % is 18.83 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qol Holdings Co (TSE:3034) Overvalued in 2026?
Based on GuruFocus' analysis, Qol Holdings Co stock appears to be overvalued.
The current stock price of 円2,638.00 is trading 14.9% above its estimated GF Value™ of 円2,296.33.
GuruFocus considers Qol Holdings Co to be Modestly Overvalued.
Key valuation signals for TSE:3034:
OCF Yield %: 18.83
GF Value™: 円2,296.33 vs. price of 円2,638.00 (14.9% above fair value)
Industry Position: 260% above the Healthcare Providers & Services median (#83 of 679)
No single metric tells the full story. See the TSE:3034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.
86GF Score
Get the complete analysis for TSE:3034
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3034 has been successfully added to your 
